【24h】

A p. vaccination of a genetic model of Alzheimer's disease

机译:一个p。阿尔茨海默病遗传模型的疫苗接种

获取原文

摘要

Alzheimer's disease (AD), the pathological hallmarks of which are amyloid plaques, neuroflbrittary tangles and neuronal loss, is the most common dementia in elderly persons. To date, much evidence supports the hypothesis that the excess extracellular deposition of amyloid p-peptide (Ap) is the most likely initiator of the pathogenesis of the disease. Recently, immunization of Ap in PDAPP transgenic mouse model of AD was reported to reduce the burden of amyloid in the central nervous system. We show here that immunization results in an ~ 50% reduction in dense-core amyloid plaques and an improvement in cognitive impairment in both the young and old TgCRNDS murine model of AD, without changing the total amount of Ap in the brain. The induced sera had strong immunoreactivity with dense-cored Ap plaques, not with the amyloid precursor protein, and reduced Ap fibril formation and cytotoxicity of Ap in vitro.
机译:阿尔茨海默病(广告),其病理标志是淀粉样斑块,神经织地缠结和神经元损失,是老年人最常见的痴呆。迄今为止,许多证据支持淀粉样蛋白P-肽(AP)的过度细胞外沉积是该疾病发病机制最有可能引发剂的假设。最近,据报道,AP在广告中的PDAPP转基因小鼠模型中的免疫免疫,以减少中枢神经系统中淀粉样蛋白的负担。我们在这里展示免疫导致致密核淀粉样斑块的〜50%降低,并且在AD的年轻TGCRNDS鼠模型中的认知障碍提高,而不会改变大脑中AP的总量。诱导的血清具有强烈的免疫反应性,与致密芯片斑块,而不是淀粉样蛋白前体蛋白质,并在体外减少AP的AP纤维形成和细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号